Crawford Fund Management »

Bridgebio Pharma shares owned by Crawford Fund Management

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Crawford Fund Management from 13F filings

Historical chart of Crawford Fund Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Crawford Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Crawford Fund Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $860k 28k 30.92

More positions owned by Crawford Fund Management

General Motors Company Put Option (GM)
Moderna Put Option (MRNA)
Pfizer Put Option (PFE)
Atkore Intl (ATKR)
Affirm Hldgs Com Cl A Put Option (AFRM)
United Therapeutics Corporation (UTHR)
Digitalocean Hldgs Put Option (DOCN)
Interactive Brokers Group In Com Cl A (IBKR)
Rivian Automotive Com Cl A Put Option (RIVN)
Nexstar Media Group Common Stock (NXST)
Nextera Energy Partners Com Unit Part In Put Option (NEP)
Norwegian Cruise Line Hldg L SHS Put Option (NCLH)
Nelnet Cl A (NNI)
Customers Ban (CUBI)
Nathan's Famous (NATH)

View all positions for Crawford Fund Management

Top funds holding Bridgebio Pharma

Kohlberg Kravis Roberts & Co
Viking Global Investors
Vanguard Group
BlackRock
Aisling Capital Management
State Street Corporation
Laurion Capital Management
UBS Group
Frazier Life Sciences Management
Henderson Group
Cormorant Asset Management
Pictet Asset Management Holding SA
Geode Capital Management
Alliancebernstein
Lord, Abbett & Co

View all funds holding Bridgebio Pharma